The main office of represented VC is situated in the Charlotte. The fund was located in North America if to be more exact in United States.
The current fund was established by Erskine Bowles. We also calculated 1 valuable employee in our database.
The fund is constantly included in less than 2 deals per year. Comparing to the other companies, this Kitty Hawk Capital performs on 0 percentage points less the average number of lead investments. The common things for fund are deals in the range of 10 - 50 millions dollars. The important activity for fund was in 2003. The higher amount of exits for fund were in 2011.
The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the Kitty Hawk Capital, startups are often financed by Johnson & Johnson Development Corporation, Intersouth Partners, Wakefield Group. The meaningful sponsors for the fund in investment in the same round are Intersouth Partners, Wakefield Group, Quaker BioVentures. In the next rounds fund is usually obtained by Johnson & Johnson Development Corporation, Quaker BioVentures, Mitsui Global Investment.
Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Synageva BioPharma, Biolex Therapeutics, ScoreBoard. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. We can highlight the next thriving fund investment areas, such as Information Technology, Therapeutics.
Related Funds
Funds with similar focus
Fund Name | Location |
Investor AB | Stockholm, Stockholm County, Sweden |
KBC Securities | - |
Millennium Bank SA | Brazil, Rio Grande do Sul, Viamão |
Parakletos Ventures | California, San Jose, United States |
shenzhoufu | Beijing, Beijing, China |
Starbucks | Seattle, United States, Washington |
Startupbootcamp Smart City Dubai | Dubai, United Arab Emirates |
TECHU | New York, New York, United States |
Wanwu Capital | - |
Yeahmobi | Beijing, Beijing, China |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Biolex Therapeutics | $36M | 01 Sep 2005 | North Carolina, United States | ||
NetOctave | $7M | 11 Feb 2002 | North Carolina, United States | ||
ScoreBoard | $25M | 21 Jul 2000 | Virginia, United States | ||
ScoreBoard | $4M | 14 Sep 1999 | Virginia, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Biolex Therapeutics | $36M | 01 Sep 2005 | North Carolina, United States | ||
NetOctave | $7M | 11 Feb 2002 | North Carolina, United States | ||
ScoreBoard | $25M | 21 Jul 2000 | Virginia, United States | ||
ScoreBoard | $4M | 14 Sep 1999 | Virginia, United States |